Unique ID issued by UMIN | UMIN000039467 |
---|---|
Receipt number | R000044956 |
Scientific Title | Usefulness of laminin gamma 2 (LG2m) as predictive factor for the development of hepatocellular carcinoma |
Date of disclosure of the study information | 2020/02/12 |
Last modified on | 2020/02/12 18:33:10 |
Usefulness of laminin gamma 2 (LG2m) as predictive factor for the development of hepatocellular carcinoma
Usefulness of laminin gamma 2 (LG2m) as predictive factor for the development of hepatocellular carcinoma
Usefulness of laminin gamma 2 (LG2m) as predictive factor for the development of hepatocellular carcinoma
Usefulness of laminin gamma 2 (LG2m) as predictive factor for the development of hepatocellular carcinoma
Japan |
Patients with risk factors for hepatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Others
NO
To investigate the usefulness of Laminin2 as predictive factor for the development of hepatocellular carcinoma
Efficacy
incidence of hepatocellular carcinoma
Observational
20 | years-old | <= |
90 | years-old | > |
Male and Female
1) Patients
Cohort 1: previously diagnosed as chronic hepatitis C and achieved sustained virological responses
Cohort 1: currently diagnosed as chronic hepatitis B and receive nucleos (t) ide analogues
Cohort 3: diagnosed as alcoholic liver injury
Cohort 4: diagnosed as diabetes mellitus and over 50 years of age
Cohort 5: diagnosed as fatty liver and over 50 years of age
2) having no history of hepatocellular carcinoma
3) age at entry is
Cohort1,2,3: 20 years or older and younger than 90 years
Cohort4,5: 50 years or older and younger than 90 years
4)
Cohort1: obtaining sustained viral response by direct-acting antiviral agent
Cohort2: receiving nucleos(t)ide analogue and suppressing HBV-DNA under 3.0 LogIU/mL
Cohort3: consuming alcohol of 60g or more
1) hepatocellular carcinoma
2) acute hepatitis
3) decompensated liver cirrhosis
4) having an active malignancy
5) serious complications
6) having an infection (except for viral hepatitis)
7) having a psychiatric disorder or psychiatric symptom
8) inappropriate for participant of this study
5800
1st name | Shuichi |
Middle name | |
Last name | Kaneko |
Kanazawa University Hospital
Department of Gastroenterology
920-8641
13-1, Takaramachi, Kanazawa, Ishikawa, Japan
076-265-2235
skaneko@m-kanazawa.jp
1st name | Takeshi |
Middle name | |
Last name | Terashima |
Kanazawa University Hospital
Department of Gastroenterology
920-8641
13-1, Takaramachi, Kanazawa, Ishikawa, Japan
076-265-2235
tera20jp@gmail.com
Kanazawa University
AMED
Japanese Governmental office
Medical Ethics Committee of Kanazawa University
13-1, Takaramachi, Kanazawa, Ishikawa, Japan
076-265-2832
rinri@adm.kanazawa-u.ac.jp
NO
2020 | Year | 02 | Month | 12 | Day |
Unpublished
Open public recruiting
2019 | Year | 12 | Month | 03 | Day |
2019 | Year | 12 | Month | 18 | Day |
2020 | Year | 02 | Month | 12 | Day |
2023 | Year | 03 | Month | 31 | Day |
To investigate the usefulness of Laminin2 as predictive factor for the development of hepatocellular carcinoma
2020 | Year | 02 | Month | 12 | Day |
2020 | Year | 02 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044956
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |